Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.410 | 1.540 | 0.130 |
Stocks | 98.590 | 98.590 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 25.640 | 30.885 |
Price to Book | 5.839 | 6.554 |
Price to Sales | 4.349 | 4.562 |
Price to Cash Flow | 19.264 | 19.209 |
Dividend Yield | 0.761 | 0.642 |
5 Years Earnings Growth | 14.146 | 14.855 |
Name | Net % | Category Average |
---|---|---|
Technology | 41.120 | 36.046 |
Healthcare | 19.590 | 14.985 |
Industrials | 11.740 | 7.999 |
Financial Services | 10.770 | 10.489 |
Communication Services | 9.300 | 11.368 |
Consumer Cyclical | 6.470 | 13.769 |
Utilities | 1.000 | 1.822 |
Number of long holdings: 59
Number of short holdings: 11
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft Corp | - | 9.88 | - | - | |
NVIDIA Corp | - | 6.47 | - | - | |
Alphabet Inc Class A | - | 6.27 | - | - | |
Apple Inc | - | 5.81 | - | - | |
Eli Lilly | US5324571083 | 4.77 | 787.24 | +3.22% | |
Mastercard | US57636Q1040 | 3.74 | 458.04 | +0.85% | |
Broadcom Inc | - | 3.67 | - | - | |
Meta Platforms Inc Class A | - | 2.89 | - | - | |
UnitedHealth | US91324P1021 | 2.76 | 517.50 | +0.70% | |
Thermo Fisher Scientific | US8835561023 | 2.68 | 598.54 | +0.63% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
SE0011309707 | 113.93B | 14.45 | 13.03 | 14.03 | ||
SE0010127894 | 47.76B | 10.79 | 9.88 | - | ||
Handelsbanken Global Tema (A1 SEK) | 43.16B | 15.89 | 10.70 | 14.10 | ||
Handelsbanken Global Tema (B1 SEK) | 43.16B | 15.89 | 10.70 | - | ||
Handelsbanken Multi Asset 50 A1 S | 32.37B | 6.58 | 4.31 | 6.15 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review